Dr. Avneet K Bawa, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 11908 Darnestown Rd, Suites G & H, N Potomac, MD 20878 Phone: 301-990-6333 Fax: 301-519-0474 |
News Archive
People are living longer than ever. The average age of the population is increasing. Yet the number of people with multiple chronic health problems, called multimorbidity, is also growing.
Semafore Pharmaceuticals today announced today announced the United States Patent and Trademark Office (PTO) has issued United States Patent Number 7,662,977 entitled "PI-3 Kinase Inhibitor Prodrugs." This composition of matter patent covers a genus of novel compounds that includes SF1126, Semafore's clinical stage, small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K signaling pathway that is vital to several essential biological processes, such as cell proliferation and survival.
Hispanic adults vary widely in their reported trust of health information sources, suggesting that information tailored to specific ethnic subgroups and targeted by age group may be beneficial, according to results of a study by SUNY Downstate Assistant Professor Marlene Camacho-Rivera, MS, MPH, ScD.
This non-invasive diagnostic method could help detect the disease in its earliest stages with a small urine sample.
› Verified 6 days ago